Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-22-000105 General Corporate
Debt relative to revenue 80th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
116.03% · OPTIONAL · VALID
Capex intensity 57th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.48% · OPTIONAL · VALID
Operating cash generation 64th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.38% · OPTIONAL · VALID
Revenue growth 64th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
17.03% · CORE · VALID
Inventory pressure 27th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
49.09% · OPTIONAL · VALID
Operating margin 80th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
9.49% · CORE · VALID
SBC intensity 73th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.95% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 124.37%
Current 116.03%
Delta -8.35% Capex Intensity Decreased
Previous 4.83%
Current 4.48%
Delta -0.35% Cash Generation Increased
Previous 4.57%
Current 14.38%
Delta 9.81% Growth Decreased
Previous 21.66%
Current 17.03%
Delta -4.64% Inventory Pressure Decreased
Previous 63.98%
Current 49.09%
Delta -14.89% Profitability Increased
Previous 6.48%
Current 9.49%
Delta 3.01% Sbc Intensity Increased
Previous 0.82%
Current 0.95%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.